Ligand Pharmaceuticals
LGND
LGND
192 hedge funds and large institutions have $1.3B invested in Ligand Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 85 increasing their positions, 61 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
192
Holders Change
+8
Holders Change %
+4.35%
% of All Funds
5.52%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.17%
New
30
Increased
85
Reduced
61
Closed
22
Calls
$8.25M
Puts
$13.8M
Net Calls
-$5.6M
Net Calls Change
-$8.02M
Top Buyers
| 1 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$15.2M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
+$10.6M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$9.37M |
| 4 |
NAM
Nichols Asset Management
Sudbury,
Massachusetts
|
+$8.12M |
| 5 |
Goldman Sachs
New York
|
+$4.64M |
Top Sellers
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$15M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$12.7M |
| 3 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$9.6M |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
-$8.43M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$7.34M |
